Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by cactuseskimoon Apr 02, 2021 2:29pm
131 Views
Post# 32932446

RE:RE:RE:RE:RE:RE:Health Clinics patent for cancer treatment

RE:RE:RE:RE:RE:RE:Health Clinics patent for cancer treatment

You seem to miss the point. SZLS was so successful with Covid testing because they chose multiple partner clinics and distributors to get their tests to market. Everyone expected them to continue this model with Aristotle. Instead, they are attempting to do it all themselves instead. Hence the "so dissapointing" analyst comment.

Nailbiter1 wrote:

cactuseskimo wrote:

Obviously, it's a simple analogy to make a single point. Of course it's different than cancer. But, would you rather that Stagezero set up its own Covid testing clinic, or did what they did wirking with multiple partners and clinics?

 

Nailbiter1 wrote:

 

cactuseskimo wrote:

In theory, yes. But right now, it seems akin to Heinz saying we aren't going to target grocery stores to sell our products anymore, and instead are going to set up a couple of our own stores. 

 

Mykndrsn wrote: One stop for test and treatment is a great plan. 

 

 


Not at all. Cancer diags through treatment and follow up is not like buying ketchup.

This is complicated and offers reassurance at a time when the patient can feel overwhelmed.

It was a concern of employer groups we courted and now we addressed it fully.
 

 

AVRT and the new game plan has nothing to do with covid. It is strictly Aristotle and cancer as well as Aristotle and other diseases.
Covid continues as it always has. Ichor is now offering mail in kits to homes in Canada. SZLS will probably do the same.



<< Previous
Bullboard Posts
Next >>